Post-pandemic insights on COVID-19 and premature ovarian insufficiency
The COVID-19 pandemic has raised concerns regarding its potential impact on premature ovarian insufficiency (POI). This overview examines the possible interactions between COVID-19 and POI, while also suggesting preventive measures. The viral infection’s inflammatory response and immune dysregulatio...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2025-01-01
|
Series: | Open Life Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1515/biol-2022-1028 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832570523100381184 |
---|---|
author | Han Yaguang Dai Yang Wang Kexin Zhang Xin Shao Zishen Zhu Xiaolin |
author_facet | Han Yaguang Dai Yang Wang Kexin Zhang Xin Shao Zishen Zhu Xiaolin |
author_sort | Han Yaguang |
collection | DOAJ |
description | The COVID-19 pandemic has raised concerns regarding its potential impact on premature ovarian insufficiency (POI). This overview examines the possible interactions between COVID-19 and POI, while also suggesting preventive measures. The viral infection’s inflammatory response and immune dysregulation may adversely affect ovarian tissues, leading to inflammation and damage. Additionally, alterations in vascular function could impair ovarian blood flow and hormonal imbalances may disrupt normal ovarian function. Long-term health effects, such as “long COVID,” may exacerbate these issues through chronic inflammation and immune dysfunction. Public health measures, such as vaccination and home isolation, may indirectly protect ovarian health by reducing systemic inflammation. Vaccines could mitigate the severity of COVID-19’s impact on ovarian function, while isolation may reduce stress and inflammation. However, further research is needed to validate these mechanisms. |
format | Article |
id | doaj-art-b7ec826092aa486aa3cb32720eae0b7d |
institution | Kabale University |
issn | 2391-5412 |
language | English |
publishDate | 2025-01-01 |
publisher | De Gruyter |
record_format | Article |
series | Open Life Sciences |
spelling | doaj-art-b7ec826092aa486aa3cb32720eae0b7d2025-02-02T15:44:51ZengDe GruyterOpen Life Sciences2391-54122025-01-012016269248210.1515/biol-2022-1028Post-pandemic insights on COVID-19 and premature ovarian insufficiencyHan Yaguang0Dai Yang1Wang Kexin2Zhang Xin3Shao Zishen4Zhu Xiaolin5Department of Medicine, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, 150040, ChinaDepartment of Medicine, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, 150040, ChinaDepartment of Medicine, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, 150040, ChinaDepartment of Medicine, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, 150040, ChinaDepartment of Medicine, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, 150040, ChinaDepartment of Medicine, Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, No. 411 Guogeli Street, Nangang District, Harbin, Heilongjiang, 150006, P.R. ChinaThe COVID-19 pandemic has raised concerns regarding its potential impact on premature ovarian insufficiency (POI). This overview examines the possible interactions between COVID-19 and POI, while also suggesting preventive measures. The viral infection’s inflammatory response and immune dysregulation may adversely affect ovarian tissues, leading to inflammation and damage. Additionally, alterations in vascular function could impair ovarian blood flow and hormonal imbalances may disrupt normal ovarian function. Long-term health effects, such as “long COVID,” may exacerbate these issues through chronic inflammation and immune dysfunction. Public health measures, such as vaccination and home isolation, may indirectly protect ovarian health by reducing systemic inflammation. Vaccines could mitigate the severity of COVID-19’s impact on ovarian function, while isolation may reduce stress and inflammation. However, further research is needed to validate these mechanisms.https://doi.org/10.1515/biol-2022-1028covid-19premature ovarian insufficiencyimmune dysregulationclinical preventionpublic health |
spellingShingle | Han Yaguang Dai Yang Wang Kexin Zhang Xin Shao Zishen Zhu Xiaolin Post-pandemic insights on COVID-19 and premature ovarian insufficiency Open Life Sciences covid-19 premature ovarian insufficiency immune dysregulation clinical prevention public health |
title | Post-pandemic insights on COVID-19 and premature ovarian insufficiency |
title_full | Post-pandemic insights on COVID-19 and premature ovarian insufficiency |
title_fullStr | Post-pandemic insights on COVID-19 and premature ovarian insufficiency |
title_full_unstemmed | Post-pandemic insights on COVID-19 and premature ovarian insufficiency |
title_short | Post-pandemic insights on COVID-19 and premature ovarian insufficiency |
title_sort | post pandemic insights on covid 19 and premature ovarian insufficiency |
topic | covid-19 premature ovarian insufficiency immune dysregulation clinical prevention public health |
url | https://doi.org/10.1515/biol-2022-1028 |
work_keys_str_mv | AT hanyaguang postpandemicinsightsoncovid19andprematureovarianinsufficiency AT daiyang postpandemicinsightsoncovid19andprematureovarianinsufficiency AT wangkexin postpandemicinsightsoncovid19andprematureovarianinsufficiency AT zhangxin postpandemicinsightsoncovid19andprematureovarianinsufficiency AT shaozishen postpandemicinsightsoncovid19andprematureovarianinsufficiency AT zhuxiaolin postpandemicinsightsoncovid19andprematureovarianinsufficiency |